Anil Bhanudas Gaikwad

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Angiotensin Converting Enzyme

Rheumatoid Arthritis Patients

Acute Kidney Injury

Top Venues

Cell biochemistry and function

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Fundamental & clinical pharmacology

Journal of molecular medicine (Berlin, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Hrushikesh Kulkarni, Neha Dagar, Anil Bhanudas Gaikwad
Targeting polo-like kinase 1 to treat kidney diseases. Cell biochemistry and function 42 (5) (2024)
Swati Mishra, Vishwadeep Shelke, Neha Dagar, Maciej Lech, Anil Bhanudas Gaikwad
Molecular insights into P2X signalling cascades in acute kidney injury. Purinergic signalling (2024)
Shubhangi Saxena, Neha Dagar, Vishwadeep Shelke, Bhupendra Puri, Anil Bhanudas Gaikwad
Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management. Fundamental & clinical pharmacology (2024)
Swati Mishra, Vishwadeep Shelke, Anil Bhanudas Gaikwad
Acyl-CoA Synthetase Long-Chain Isoenzymes in Kidney Diseases: Mechanistic Insights and Therapeutic Implications. Cell biochemistry and function 42 (7) (2024)
Hrushikesh Kulkarni, Neha Dagar, Anil Bhanudas Gaikwad
Targeting polo-like kinase 1 to treat kidney diseases. Cell biochemistry and function 42 (5) (2024)
Ajinath Kale, Maciej Lech, Hans-Joachim Anders, Anil Bhanudas Gaikwad
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Ajinath Kale, Maciej Lech, Hans-Joachim Anders, Anil Bhanudas Gaikwad
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Vishwadeep Shelke, Ajinath Kale, Neha Dagar, Tahib Habshi, Anil Bhanudas Gaikwad
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury. Food & function (2023)
Ajinath Kale, Maciej Lech, Hans-Joachim Anders, Anil Bhanudas Gaikwad
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Vishwadeep Shelke, Ajinath Kale, Hans-Joachim Anders, Anil Bhanudas Gaikwad
Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease. Journal of molecular medicine (Berlin, Germany) 100 (7) (2022)
Himanshu Sankrityayan, Ajinath Kale, Nisha Sharma, Hans-Joachim Anders, Anil Bhanudas Gaikwad
Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder. Journal of cardiovascular pharmacology and therapeutics 25 (4) (2020)